NCT05419973

Brief Summary

This study is a cohort study that aims to assess the relationship between Vitamin D Levels in infant and the risk of anemia, atopic dermatitis, diarrhea and cardiovascular disorders in newborn. The subjects of this study are 100 women who met the inclusion criteria, which are in their third trimester of pregnancy and agree to be included in this study. These subjects then will be examined for their weight using standardized CEBA digital scale, height, upper arm circumference, and blood sampling will also be done to these women to measure their vitamin D levels, calcium, parathyroid hormone, ferritin, Fe serum, IL-16, IL-10. When subjects give birth, the babies will also be included in this study. Anthropometric examination will also be done on the babies, to measure their birth weight, birth length, and head circumference. Blood samples will also be taken from their umbilical cord to assess their complete blood count, ferritin, Fe serum, vitamin D levels, vitamin D receptors, IL-6 and IL-10. All subjects then will be monitored, and home visits will be done when the babies reach 3 months old and 6 months old. An assessment of the incidence of diarrhea, atopic dermatitis, and an assessment of cardiovascular disorders (checking pulse and blood pressure) will be carried out during the visit. At the end of the study, venous blood sampling will be taken to see levels of vitamin D, calcium, parathyroid hormone, routine complete blood count, serum Fe, and ferritin, then data analysis is performed.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2022

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

June 11, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 15, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2023

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

June 30, 2022

Status Verified

June 1, 2022

Enrollment Period

9 months

First QC Date

June 11, 2022

Last Update Submit

June 25, 2022

Conditions

Keywords

Vitamin D in Infants

Outcome Measures

Primary Outcomes (1)

  • Vitamin D Levels

    Measured by blood sample collection

    August 2022 - February 2023

Secondary Outcomes (5)

  • Hemoglobin levels

    August 2022 - February 2023

  • IgE

    August 2022 - February 2023

  • Atopic Dermatitis

    August 2022 - February 2023

  • Diarrhea

    August 2022 - February 2023

  • Hypertension

    August 2022 - February 2023

Study Arms (2)

Pregnant Women

Women in third semester of pregnancy who are willing to include their babies as samples for the next study, no history of abortion, and not suffering from hypertension and preeclampsia.

Other: Anthropometric measurement for pregnant womenOther: Blood sampling

Infants

Babies born from mothers who are willing to be included in the study, aterm, with birth weight more than 2500 grams. No congenital abnormalities at birth and no acute infection at birth.

Other: Anthropometric measurement for infantsOther: Blood sampling

Interventions

Weight, length, upper arm circumference

Pregnant Women

birth weight, length, head circumference, nutritional status

Infants

3 ml of blood will be taken, 1,5 ml each to measure the complete blood count, and other 1,5 ml to measure ferritin, Fe serum, vitamin D levels, vitamin D receptors, IL-6 and IL-10.

InfantsPregnant Women

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Women in third trimester of pregnancy in Makassar, Surabaya, Mataram who are selected during the screening test.

You may qualify if:

  • Women in third trimester of pregnancy
  • Agree to include their babies in this study

You may not qualify if:

  • History of abortion
  • Suffering from hypertension or preeclampsia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hasanuddin University

Makassar, South Sulawesi, 90245, Indonesia

RECRUITING

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

whole blood

MeSH Terms

Conditions

Vitamin D Deficiency

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Sri Hardiyanti Putri, MD

    Hasanuddin University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sri Hardiyanti Putri, MD

CONTACT

Bahrul Fikry, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Pediatrician, Teaching Staff at Pediatric Department Hasanuddin University

Study Record Dates

First Submitted

June 11, 2022

First Posted

June 15, 2022

Study Start

May 15, 2022

Primary Completion

February 1, 2023

Study Completion

March 1, 2023

Last Updated

June 30, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will share

We are going to share individual participant data that underlie results in this publication

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
6 months after publication
Access Criteria
The data will be shared by email sent by the primary investigator

Locations